Cancer procoagulant--CP.
A review of literature concerning cancer procoagulant (CP) has been carried out. This procoagulant directly activates coagulation factor X to factor Xa. Possibilities of utilising determinations of this activator in diagnostics and prognostics of the cancerous disease are discussed.
Rucińska
M
M
Department of Oncology, Medical Academy of Białystok.
Gacko
M
M
Skrzydlewski
Z
Z
D000818:Animals; D014408:Biomarkers, Tumor / Q000097:blood; D001778:Blood Coagulation Disorders / Q000209:etiology; D006224:Cricetinae; D003546:Cysteine Endopeptidases / Q000032:analysis / Q000502:physiology*; D004789:Enzyme Activation; D004797:Enzyme-Linked Immunosorbent Assay; D005170:Factor X / Q000378:metabolism; D015951:Factor Xa / Q000096:biosynthesis; D006801:Humans; D051379:Mice; D009363:Neoplasm Proteins; D009369:Neoplasms / Q000097:blood / Q000150:complications / Q000201:enzymology*; D009374:Neoplasms, Experimental / Q000097:blood / Q000150:complications / Q000201:enzymology; D011817:Rabbits; D051381:Rats; D012680:Sensitivity and Specificity
D014408:Biomarkers, Tumor; D009363:Neoplasm Proteins; D005170:Factor X; D015951:Factor Xa; D003546:Cysteine Endopeptidases; C030910:cancer procoagulant